688526 科前生物
已收盘 09-11 15:00:01
资讯
新帖
简况
每周股票复盘：科前生物（688526）拟回购注销112万余股
证券之星 · 03:19
每周股票复盘：科前生物（688526）拟回购注销112万余股
每周股票复盘：科前生物（688526）拟8元/股回购112万股
证券之星 · 09-06
每周股票复盘：科前生物（688526）拟8元/股回购112万股
股市必读：科前生物新发布《武汉科前生物股份有限公司2026年第一次临时股东会会议材料》
证券之星 · 09-01
股市必读：科前生物新发布《武汉科前生物股份有限公司2026年第一次临时股东会会议材料》
科前生物（688526）披露拟回购注销员工持股计划未解锁股份，8月31日股价上涨0.08%
证券之星 · 08-31
科前生物（688526）披露拟回购注销员工持股计划未解锁股份，8月31日股价上涨0.08%
科前生物（688526）2026年中报简析：净利润同比下降47.37%，三费占比上升明显
证券之星 · 08-28
科前生物（688526）2026年中报简析：净利润同比下降47.37%，三费占比上升明显
图解科前生物中报：第二季度单季净利润同比下降67.32%
证券之星 · 08-27
图解科前生物中报：第二季度单季净利润同比下降67.32%
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
证券之星 · 08-26
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
证券之星 · 08-25
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
科前生物最新公告：获批禽腺病毒灭活疫苗新兽药注册证书
证券之星 · 08-24
科前生物最新公告：获批禽腺病毒灭活疫苗新兽药注册证书
每周股票复盘：科前生物（688526）拟投200万合作研发新兽药
证券之星 · 08-16
每周股票复盘：科前生物（688526）拟投200万合作研发新兽药
股市必读：科前生物新发布《武汉科前生物股份有限公司关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》
证券之星 · 08-12
股市必读：科前生物新发布《武汉科前生物股份有限公司关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》
科前生物(688526.SH)拟与华中农大签订合作研发协议
智通财经 · 08-11
科前生物(688526.SH)拟与华中农大签订合作研发协议
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
证券之星 · 08-03
股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》
每周股票复盘：科前生物（688526）获两项新兽药注册证
证券之星 · 08-02
每周股票复盘：科前生物（688526）获两项新兽药注册证
科前生物（688526）披露获批两项新兽药注册证书，7月30日股价上涨0.48%
证券之星 · 07-30
科前生物（688526）披露获批两项新兽药注册证书，7月30日股价上涨0.48%
科前生物（688526）披露拟签订合作研发协议暨关联交易公告，7月14日股价上涨1.18%
证券之星 · 07-14
科前生物（688526）披露拟签订合作研发协议暨关联交易公告，7月14日股价上涨1.18%
每周股票复盘：科前生物（688526）将举办2025年度业绩说明会
证券之星 · 07-05
每周股票复盘：科前生物（688526）将举办2025年度业绩说明会
科前生物获得发明专利授权：“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”
证券之星 · 07-04
科前生物获得发明专利授权：“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”
科前生物（688526）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨5.12%
证券之星 · 07-01
科前生物（688526）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨5.12%
太平洋：给予科前生物买入评级
证券之星 · 06-15
太平洋：给予科前生物买入评级
暂无数据
公司概况
公司名称：
武汉科前生物股份有限公司
所属行业：
医药制造业
上市日期：
2020-09-22
主营业务：
武汉科前生物股份有限公司的主营业务是专注于兽用生物制品研发、生产、销售及动物防疫技术服务。公司的主要产品是非国家强制免疫猪用疫苗、禽用疫苗。
发行价格：
11.69
{"stockData":{"symbol":"688526","market":"SH","secType":"STK","nameCN":"科前生物","latestPrice":12.48,"timestamp":1789110001000,"preClose":12.75,"halted":0,"volume":1557321,"delay":0,"changeRate":-0.0212,"floatShares":466000000,"shares":466000000,"eps":0.6749,"marketStatus":"已收盘","change":-0.27,"latestTime":"09-11 15:00:01","open":12.66,"high":12.7,"low":12.42,"amount":19462900,"amplitude":0.022,"askPrice":12.5,"askSize":3,"bidPrice":12.48,"bidSize":267,"shortable":0,"etf":0,"ttmEps":0.6749,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":12.75,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":14.03,"lowLimit":11.48,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":466128056,"isCdr":false,"pbRate":1.44,"roa":"--","peRate":18.491628,"roe":"2.77%","epsLYR":0.9,"committee":0.887381,"marketValue":5817000000,"turnoverRate":0.0033,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-14。","afterMarket":{"amount":0,"volume":0,"close":12.48,"buyVolume":0,"sellVolume":6100,"time":1789112037746,"indexStatus":"已收盘 09-11 15:30:00","preClose":12.75},"floatMarketCap":5817000000},"requestUrl":"/m/hq/s/688526/tweets","defaultTab":"tweets","newsList":[{"id":"2667504500","title":"每周股票复盘：科前生物（688526）拟回购注销112万余股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667504500","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667504500?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:19","pubTimestamp":1789240749,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，科前生物报收于12.48元，较上周的12.78元下跌2.35%。武汉科前生物股份有限公司因2025年员工持股计划部分股份未解锁，拟回购注销1,124,537股股票，回购价格为8元/股。本次回购注销将导致公司总股本由466,128,056股减少至465,003,519股，注册资本相应减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665598366","title":"每周股票复盘：科前生物（688526）拟8元/股回购112万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665598366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665598366?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:30","pubTimestamp":1788636628,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，科前生物报收于12.78元，较上周的12.62元上涨1.27%。本周关注点公司公告汇总：科前生物拟以8元/股价格回购注销1,124,537股股份。武汉科前生物股份有限公司将于2026年09月10日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800005","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司2026年第一次临时股东会会议材料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664800005?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:23","pubTimestamp":1788204216,"startTime":"0","endTime":"0","summary":"公司公告汇总武汉科前生物股份有限公司2026年第一次临时股东会会议材料武汉科前生物股份有限公司拟以8元/股的价格回购注销2025年员工持股计划中因解锁条件未成就的1,124,537股股份，并相应减少注册资本，修订公司章程并办理工商变更登记。武汉科前生物股份有限公司2026年半年度业绩说明会公告武汉科前生物股份有限公司将于2026年09月10日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果及财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100003970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077173","title":"科前生物（688526）披露拟回购注销员工持股计划未解锁股份，8月31日股价上涨0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077173","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077173?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:12","pubTimestamp":1788174736,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，科前生物报收于12.63元，较前一交易日上涨0.08%，最新总市值为58.87亿元。该股当日开盘12.59元，最高12.75元，最低12.48元，成交额达1901.47万元，换手率为0.32%。近日，武汉科前生物股份有限公司披露《2026年第一次临时股东会会议材料》，拟以8元/股的价格回购注销2025年员工持股计划中因解锁条件未成就的1,124,537股股份，并相应减少注册资本，修订公司章程并办理工商变更登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100030405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662355039","title":"科前生物（688526）2026年中报简析：净利润同比下降47.37%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2662355039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662355039?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:19","pubTimestamp":1787869196,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科前生物发布2026年中报。截至本报告期末，公司营业总收入3.74亿元，同比下降23.28%，归母净利润1.16亿元，同比下降47.37%。按单季度数据看，第二季度营业总收入1.46亿元，同比下降39.57%，第二季度归母净利润3648.71万元，同比下降67.32%。本报告期科前生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达35.82%。然而去年的净利率为43.9%，算上全部成本后，公司产品或服务的附加值极高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662174675","title":"图解科前生物中报：第二季度单季净利润同比下降67.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662174675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662174675?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:58","pubTimestamp":1787767123,"startTime":"0","endTime":"0","summary":"证券之星消息，科前生物2026年中报显示，上半年度公司主营收入3.74亿元，同比下降23.28%；归母净利润1.16亿元，同比下降47.37%；扣非净利润8569.68万元，同比下降54.89%；其中2026年第二季度，公司单季度主营收入1.46亿元，同比下降39.57%；单季度归母净利润3648.71万元，同比下降67.32%；单季度扣非净利润1624.49万元，同比下降83.48%；负债率10.68%，投资收益452.37万元，财务费用-1873.55万元，毛利率59.42%。财报数据概要请见下图:本文数据来源于科前生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700005882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750942","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750942","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662750942?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:26","pubTimestamp":1787696804,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，科前生物报收于13.1元，上涨1.0%，换手率0.26%，成交量1.19万手，成交额1561.73万元。公司公告汇总武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告武汉科前生物股份有限公司公告，其申报的禽腺病毒灭活疫苗获农业农村部批准为新兽药，研制单位为华中农业大学和公司。该疫苗用于预防禽腺病毒病，免疫产生期28日，免疫期4个月。产品尚需取得批准文号方可生产销售，上市时间及市场推广存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205736","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205736","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662205736?lang=zh_cn&edition=full","pubTime":"2026-08-25 03:51","pubTimestamp":1787601071,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，科前生物报收于12.97元，下跌0.92%，换手率0.29%，成交量1.35万手，成交额1747.25万元。公司公告汇总武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告武汉科前生物股份有限公司公告，其申报的禽腺病毒灭活疫苗获农业农村部批准为新兽药，研制单位为华中农业大学和公司。该疫苗用于预防禽腺病毒病，免疫产生期28日，免疫期4个月。产品尚需取得批准文号方可生产销售，上市时间及市场推广存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500008151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220705","title":"科前生物最新公告：获批禽腺病毒灭活疫苗新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220705","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220705?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:20","pubTimestamp":1787566813,"startTime":"0","endTime":"0","summary":"科前生物(688526.SH)公告称，公司申报的禽腺病毒(I群，4型)灭活疫苗(HB-2株)经农业农村部审查批准为新兽药，并核发《新兽药注册证书》。该疫苗用于预防禽腺病毒引起的禽腺病毒病，免疫产生期为28日，免疫期为4个月。此次获批将丰富公司禽用疫苗产品布局，提升市场竞争力，但后续尚需申报生产文号，产品销售存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659764511","title":"每周股票复盘：科前生物（688526）拟投200万合作研发新兽药","url":"https://stock-news.laohu8.com/highlight/detail?id=2659764511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659764511?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:29","pubTimestamp":1786822149,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，科前生物报收于13.05元，较上周的12.95元上涨0.77%。本周关注点公司公告汇总：科前生物拟与华中农大合作研发两项猪用疫苗检测产品，合计投入200万元。公司公告汇总武汉科前生物股份有限公司拟与华中农业大学签订“猪流行性腹泻病毒乳胶微球检测试纸条”和“猪流行性腹泻亚单位疫苗”两项合作研发协议，合计支付研发费用200万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600001058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658917011","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司关于拟与华中农大签订合作研发协议暨关联交易的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658917011?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:36","pubTimestamp":1786473374,"startTime":"0","endTime":"0","summary":"武汉科前生物股份有限公司独立董事关于第四届董事会第二十三次会议相关事项的独立意见独立董事认为公司拟与华中农大签订合作研发协议有利于提升公司在生物制品领域的核心竞争力，推动公司发展；该关联交易表决程序合法，交易价格公允，未损害公司及全体股东利益；独立董事一致同意本次关联交易事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998187","title":"科前生物(688526.SH)拟与华中农大签订合作研发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998187","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658998187?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:00","pubTimestamp":1786435219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科前生物(688526.SH)发布公告，公司经与华中农业大学(下称“华中农大”)竞争性谈判，取得了“猪流行性腹泻病毒乳胶微球检测试纸条”、“猪流行性腹泻亚单位疫苗”两个项目的合作研发，现拟与华中农大签订联合开发协议书，公司就以上两个研发项目一共需向华中农大支付200万元。合作研发项目产生的技术成果及知识产权归公司及华中农大共同所有。通过合作研发，可以增加公司产品储备，提升公司市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343713","title":"股市必读：科前生物新发布《武汉科前生物股份有限公司关于获批新兽药注册证书的自愿性信息披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343713?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:40","pubTimestamp":1785699622,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，科前生物报收于13.03元，上涨2.68%，换手率0.44%，成交量2.07万手，成交额2660.9万元。当日关注点交易信息汇总：7月31日主力资金净流出2.08万元，游资净流出144.63万元，散户净流入146.71万元。公司公告汇总：科前生物获批两项新兽药注册证书，分别为猪二联灭活疫苗和鸡四联灭活疫苗，监测期均为3年，上市前尚需取得批准文号。两项产品将丰富公司产品线，提升市场竞争力；产品上市前尚需取得批准文号，存在审批及市场推广不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656319974","title":"每周股票复盘：科前生物（688526）获两项新兽药注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2656319974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656319974?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:29","pubTimestamp":1785612549,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，科前生物报收于13.03元，较上周的12.32元上涨5.76%。科前生物当前最新总市值60.74亿元，在动物保健板块市值排名4/9，在两市A股市值排名2571/5202。本周关注点公司公告汇总：科前生物获批猪流行性腹泻等二联灭活疫苗及鸡新城疫等四联灭活疫苗两项新兽药注册证书。产品上市前尚需取得批准文号，存在审批及市场推广不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655480633","title":"科前生物（688526）披露获批两项新兽药注册证书，7月30日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655480633","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655480633?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:30","pubTimestamp":1785421832,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，科前生物报收于12.69元，较前一交易日上涨0.48%，最新总市值为59.15亿元。该股当日开盘12.63元，最高12.96元，最低12.62元，成交额达2153.18万元，换手率为0.36%。近日，武汉科前生物股份有限公司发布关于获批新兽药注册证书的自愿性信息披露公告。两项产品将丰富公司产品线，提升市场竞争力。产品上市前尚需取得批准文号，存在审批及市场推广不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000039888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651102442","title":"科前生物（688526）披露拟签订合作研发协议暨关联交易公告，7月14日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651102442","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651102442?lang=zh_cn&edition=full","pubTime":"2026-07-14 23:02","pubTimestamp":1784041344,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，科前生物报收于12.86元，较前一交易日上涨1.18%，最新总市值为59.94亿元。近日，武汉科前生物股份有限公司发布关于拟与华中农业大学、辽宁省动物疫病预防控制中心签订合作研发协议暨关联交易的自愿性披露公告。公司拟共同开展“猪A群轮状病毒阻断ELISA抗体检测试剂盒”项目研发，需向华中农业大学支付20万元研究经费，研发成果及知识产权由公司与华中农业大学共同所有。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400050177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649407692","title":"每周股票复盘：科前生物（688526）将举办2025年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2649407692","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649407692?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:14","pubTimestamp":1783196053,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，科前生物报收于13.04元，较上周的11.84元上涨10.14%。科前生物当前最新总市值60.78亿元，在动物保健板块市值排名4/9，在两市A股市值排名2828/5203。本周关注点公司公告汇总：科前生物将于2026年7月9日举办2025年度业绩说明会 公司公告汇总武汉科前生物股份有限公司将于2026年7月9日14:00-17:00通过全景路演网络平台参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，以网络文字互动方式与投资者交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648420660","title":"科前生物获得发明专利授权：“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648420660","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648420660?lang=zh_cn&edition=full","pubTime":"2026-07-04 03:45","pubTimestamp":1783107927,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示科前生物新获得一项发明专利授权，专利名为“猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法”，专利申请号为CN202210642333.9，授权日为2026年7月3日。本发明提供的猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗，在预防此三种猪病，表现出较为显著的优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070400003619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648448725","title":"科前生物（688526）披露将参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，7月01日股价上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648448725","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648448725?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:56","pubTimestamp":1782917773,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，科前生物报收于12.72元，较前一交易日上涨5.12%，最新总市值为59.29亿元。该股当日开盘12.1元，最高12.75元，最低12.07元，成交额达2834.5万元，换手率为0.49%。公告显示，公司将于2026年7月9日14:00-17:00通过全景路演网络平台参加湖北辖区上市公司2026年投资者集体接待日活动暨2025年度业绩说明会，以网络文字互动方式与投资者交流。参会人员包括董事长、总经理陈慕琳女士及董事会秘书邹天天女士。活动结束后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643223567","title":"太平洋：给予科前生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2643223567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643223567?lang=zh_cn&edition=full","pubTime":"2026-06-15 08:10","pubTimestamp":1781482238,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司程晓东,李忠华近期对科前生物进行研究并发布了研究报告《2026年一季报点评：创新驱动穿越周期，宠物疫苗布局打开成长新空间》，给予科前生物买入评级。我们预计公司2026-2028年营收分别达到9.69亿、12.11亿、13.32亿，归母净利润分别为3.91亿、4.37亿、4.94亿，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有10家机构给出评级，买入评级9家，增持评级1家；过去90天内机构目标均价为18.0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500000403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688526","601099"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789263227367,"stockEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":-0.0517},{"period":"3month","weight":-0.0079},{"period":"6month","weight":-0.1816},{"period":"1year","weight":-0.2936},{"period":"ytd","weight":-0.1436}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉科前生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9669人(较上一季度减少9.29%)","perCapita":"48208股","listingDate":"2020-09-22","address":"湖北省武汉市江夏区东湖新技术开发区高新二路419号","registeredCapital":"46612万元","survey":" 武汉科前生物股份有限公司的主营业务是专注于兽用生物制品研发、生产、销售及动物防疫技术服务。公司的主要产品是非国家强制免疫猪用疫苗、禽用疫苗。","listedPrice":11.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科前生物(688526)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科前生物(688526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科前生物,688526,科前生物股票,科前生物股票老虎,科前生物股票老虎国际,科前生物行情,科前生物股票行情,科前生物股价,科前生物股市,科前生物股票价格,科前生物股票交易,科前生物股票购买,科前生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科前生物(688526)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科前生物(688526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}